Objective In the current study, we aimed to investigate fasting plasma levels of glucose,
insulin, growth hormone, IGF-1, and lipid profile in remission schizophrenia patients …

Purpose: Insulin-like growth factor 1 (IGF-1) is a trophic mediator that is regulated by growth
hormone and associated with the proliferation, development, and growth of neural cells. IGF …

Objectives The use of atypical antipsychotic drugs in patients with psychiatric illness may
result in dyslipidemia, hypertension, glucose intolerance, and abdominal obesity, which are …

Insulin-like growth factor 1 (IGF-1) plays an important role in neurogenesis and
synaptogenesis and may be implicated in schizophrenia, although data so far have been …

Background Numerous studies have implicated abnormal insulin-like growth factor 1 (IGF-1)
in the pathophysiology of schizophrenia, but findings have been inconsistent. Methods We …

Background Schizophrenia is linked with abnormal brain neurodevelopment, on which IGF-
2 (insulin-like growth factor-2) has a great impact. The purpose of this study was to assess …

Insulin-like growth factor 2 (IGF-2) and IGF binding protein 7 (IGFBP-7) have been related to
schizophrenia (SZ) due to their implication in neurodevelopment. The purpose of this study …

Accumulating evidence has shown that insulin-like growth factors (IGFs) are implicated in
schizophrenia. Altered serum levels of IGF-1 have been found in schizophrenia patients and …

Increasing evidence suggests that the inflammatory system is activated in schizophrenia and
antipsychotics may affect cytokines levels. we conducted a cross-sectional and prospective …

Previous studies have suggested that insulin-like growth factor-1 (IGF-1) is altered in
schizophrenia. The objective of this study was to investigate whether plasma IGF-1 levels …